New drug improves glucose control without increasing risk of hypoglycemia in type 2 diabetes patients
TAK-875, a new treatment for type 2 diabetes, improves glycaemic (blood sugar) control and is equally as effective as the sulphonylurea glimepiride (a common drug treatment) but has a significantly lower risk of hypoglycaemia ...
Feb 26, 2012
0
0